Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Fresh Tracks Therapeutics Inc’s current trading price is -73.58% away from its 52-week high, while its distance from the 52-week low is 84.54%. The stock’s price range during this period has varied between $0.45 and $3.14. The company, active in the Healthcare sector, saw a trading volume of around 0.72 million for the day, considerably higher average daily volume of 0.29 million observed over the last three months.
The current stock price for Fresh Tracks Therapeutics Inc (FRTX) is $0.83. The stock experienced a significant increase during the last trading session, reaching $0.88 after opening at $0.88. It dipped to a low of $0.78 before ultimately closing at $0.89.
Fresh Tracks Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $3.14 on 03/08/23, with the lowest value being $0.45 on 05/09/23.
How Financial Performance Impacts Market Capitalization
Fresh Tracks Therapeutics Inc (FRTX) has experienced a quarterly rise of 31.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.95M and boasts a workforce of 13 employees.
Decoding Analysts’ Ratings for Fresh Tracks Therapeutics Inc
As of right now, 1 analyst is rating Fresh Tracks Therapeutics Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7895, with a change in price of +0.1198. Similarly, Fresh Tracks Therapeutics Inc recorded 562,899 in trading volume during the last 100 days, posting a change of +16.88%.
How FRTX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for FRTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
FRTX Stock Stochastic Average
As of today, the raw stochastic average of Fresh Tracks Therapeutics Inc over the past 50 days is 55.12%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 26.05%. Additionally, the Stochastic %K and %D values for the company were 27.03% and 31.81%, respectively, over the past 20 days.
FRTX Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -44.70% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 62.62%. Over the past 30 days, the price of FRTX has leaped by -16.21%. And in the last five days, it has fallen by -10.81%.